Table 2 Distribution of study horses by the AAEP grade for lameness at trot (LAMET) on study days 0, 3, and 6 for the meloxicam and placebo treatment groups
Lameness at Trot | Meloxicam | Placebo | |||
|---|---|---|---|---|---|
Day | Grade | N | % | N | % |
Day 0 | None (0) | 10 | 32.3 | 3 | 10.3 |
Minimal (1) | 2 | 6.5 | 3 | 10.3 | |
Mild (2) | 3 | 9.7 | 5 | 17.2 | |
Moderate (3) | 15 | 48.4 | 16 | 55.2 | |
Serious (4) | 1 | 3.2 | 2 | 6.9 | |
Severe (5) | 0 | 0.0 | 0 | 0.0 | |
Day 3 | None (0) | 8 | 25.8 | 4 | 13.8 |
Minimal (1) | 3 | 9.7 | 2 | 6.9 | |
Mild (2) | 8 | 25.8 | 4 | 13.8 | |
Moderate (3) | 9 | 29.0 | 15 | 51.7 | |
Serious (4) | 3 | 9.7 | 3 | 10.3 | |
Severe (5) | 0 | 0.0 | 1 | 3.5 | |
Day 6 | None (0) | 12 | 38.7 | 4 | 13.8 |
Minimal (1) | 11 | 35.5 | 11 | 37.9 | |
Mild (2) | 5 | 16.1 | 2 | 6.9 | |
Moderate (3) | 3 | 9.7 | 10 | 34.5 | |
Serious (4) | 0 | 0.0 | 2 | 6.9 | |
Severe (5) | 0 | 0.0 | 0 | 0.0 | |
Total | 31 | 100.0 | 29 | 100.0 | |